Cite
HARVARD Citation
Kao, J. et al. (2021). Helicobacter pylori eradication by low‐dose rifabutin triple therapy (RHB‐105) is unaffected by high body mass index. GastroHep. 3 (7), pp. 426-434. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kao, J. et al. (2021). Helicobacter pylori eradication by low‐dose rifabutin triple therapy (RHB‐105) is unaffected by high body mass index. GastroHep. 3 (7), pp. 426-434. [Online].